Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0027 | ||||
| Gene Name | SLC22A12 | ||||
| Protein Name | Urate anion exchanger 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | OAT4L; OATL4; Organic anion transporter 4-like protein; RST; Renal-specific transporter; SLC22A12; Solute carrier family 22 member 12; URAT1 | ||||
| DT Family | Major Facilitator Superfamily (MFS) | ||||
| Organic Cation Transporter (OCT) Family | |||||
| Tissue Specificity | Detected in kidney (at protein level).Detected in fetal and adult kidney. Detected in epithelial cellsof proximal tubules in renal cortex. | ||||
| Function | This transporter regulates blood urate levels via controlling saturable urate uptake by facilitating the exchange of urate against organic anions in kediney. | ||||
| Endogenous Substrate(s) | Anions | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Oxypurinol
|
Phase 2/3 | Drug Info | Heart failure | BD1Z | [1] |
|
Uric acid
|
Phase 2/3 | Drug Info | Acute ischemic stroke | 8B11 | [2] |
|
Endogenous Metabolites (EMs) Handled by This DT |
|||||
|
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
| EM Name | PubChem CID | Detail | Experimental Material | Ref | |
| Urate | EM Info | Identified using URAT1 knockout mice | [3] | ||
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Oxypurinol | Phase 2/3 | Drug Info | Oocytes-URAT1 | Km = 794 microM | [1] |
| Uric acid | Phase 2/3 | Drug Info | Oocytes-URAT1 | Km = 357.6 microM | [2] |
| References | |||||
| 1 | Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab Dispos. 2005 Dec;33(12):1791-5. | ||||
| 2 | Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter. J Pharmacol Exp Ther. 2007 Jan;320(1):211-7. | ||||
| 3 | Transcriptome-based reconstructions from the murine knockout suggest involvement of the urate transporter, URAT1 (slc22a12), in novel metabolic pathways. Biochem Biophys Rep. 2015 Sep 1;3:51-61. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.